Treatment of paranasal sinus malignancy: the BCCA experience.

Abstract

A retrospective analysis was undertaken of 119 patients treated at the British Columbia Cancer Agency (BCCA) with a diagnosis of paranasal sinus malignancy. All patients from 1970 to 1987 were included in the review. A comparison is drawn between main treatment modalities, namely primary radiotherapy, primary surgical resection and combined therapy. Clinical characteristics of this relatively rare lesion are elucidated. Recommendations regarding optimal therapy are made on the basis of this data.